Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

NCT01293123 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Did not meet enrollment goals

Conditions

HIV

Interventions

DRUG: Raltegravir
DRUG: Efavirenz

Sponsor

University of California, San Diego

Collaborators

[object Object]